Capital Investment Analysis: Pharma Strategy

This executive training program on capital investment analysis is designed for strategy professionals in the pharma sector. It addresses the challenge of evaluating high-value investments such as clinical development programs, manufacturing capacity expansion, and research infrastructure while balancing financial returns, regulatory requirements, and clinical impact. Participants will gain the ability to apply financial analysis, assess clinical development risks, and incorporate regulatory considerations into strategic investment decisions. The program uses practical case examples and evaluation exercises to ensure strong application in pharmaceutical capital planning.